Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Forecast and Insights: Exploring Growth Trends, Market Size, and Emerging Opportunities
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What External and Internal Drivers Are Contributing to the Growth of theCell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market?
The rising incidence of cancer is anticipated to stimulate the growth of the cell and gene therapy contract development and manufacturing organization (CDMO) market. Cancer refers to a collection of diseases identified by the unregulated proliferation and dissemination of abnormal cells within the body. This rise in cancer cases can be attributed to aging populations, lifestyle modifications, environmental exposures, and enhanced detection techniques. Cell and gene therapy contract development and manufacturing organization (CDMO) plays a pivotal role in curtailing cancer incidence by creating and producing novel, targeted therapies that augment efficacy and patient results. For example, as per Macmillan Cancer Support, a charitable entity based in the UK, it is foreseen that the number of cancer patients in the UK will escalate from 3 million in 2022 to 3.5 million in 2025, 4 million by 2030, and 5.3 million by 2040. Therefore, the escalating incidence of cancer becomes a key factor propelling the growth of the cell and gene therapy contract development and manufacturing organization (CDMO) market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15753&type=smp
#What Growth Opportunities Will Drive the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market’s CAGR Through 2034?
The market size of contract development and manufacturing organizations (CDMO) in the cell and gene therapy sector has experienced substantial growth in recent years. Its value is set to rise from $5.41 billion in 2024 to $6.94 billion in 2025, reflecting a compound annual growth rate (CAGR) of 28.2%. Factors propelling growth during the historical period include enhancements in technology, pro-growth regulatory environments, surge in investments, a high incidence of genetic diseases, and a rise in strategic collaborations.
The market for contract development and manufacturing organizations (CDMO) focused on cell and gene therapy is projected to witness significant expansion in the upcoming years. It is forecasted to reach a value of $18.54 billion in 2029, marking a compound annual growth rate (CAGR) of 27.8%. Factors contributing to this growth during the forecast period encompass broadening of therapeutic applications, changes in regulation, surge in investment, technological advancements, and worldwide cooperation. The future trends predicted for this period comprise a heightened demand for individualized therapies, progression in automation and digitalization, augmentation of manufacturing capacities, the rise of innovative delivery systems, and increased attention towards sustainability and environmental impacts.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15753
Which Upcoming Market Trends and Innovations Are Set to Influence theCell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market’s Path Forward?
Key players in the cell and gene therapy contract development and manufacturing organization (CDMO) industry are striving to grow their product range with innovative solutions including PluriMatrix technology that improves scalability, productivity, and cell-based product manufacturing quality. PluriMatrix technology, a unique system designed for large-scale cell-based product manufacturing, enables broad scale 3D cell expansion, guaranteeing excellent yield along with uniform quality through a verified, completely managed, automated procedure. For example, Pluri, an Israeli biotech firm, introduced their new business wing, PluriCDMO, in January 2024, which provides cell therapy manufacturing services under contract development and manufacturing organization (CDMO). This fresh division incorporates a 47,000 square foot good manufacturing practice (GMP) cell therapy manufacturing plant. Pluri’s new division provides full-service packages from preliminary preclinical phases to late clinical testing stages and commercialization. This includes process and analytical development, scale-up, validation, logistics, automation, and regulatory certification for comparability studies, as reported in a press release. Utilizing the company’s state-of-the-art PluriMatrix technology, it offers futuristic cell therapy manufacturing services.
Who Are the Dominant Market Players Pushing the Boundaries of theCell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market?
Major companies operating in the cell and gene therapy contract development and manufacturing organization (CDMO) market are Pfizer Inc., Merck & Co. Inc., Thermo Fisher Scientific Inc., Novartis AG, FUJIFILM Diosynth Biotechnologies, AGC Biologics, Ajinomoto Co Inc., Lonza Group, Catalent Inc., Charles River Laboratories International Inc., Sartorius Stedim Biotech, Samsung Biologics Co Ltd., WuXi Biologics, Recipharm AB, Almac Group Ltd., KBI Biopharma, Rentschler Biopharma, Bio Elpida, Oxford BioMedica Plc, Avid Bioservices Inc., Cell and Gene Therapy Catapult, VGXI Inc., Genezen Laboratories Inc., Pluri Inc., OmniaBio Inc.
Order Your Report Now For A Swift Delivery:
What Are the Core Segments of the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, and How Do They Contribute to Growth?
The cell and gene therapy contract development and manufacturing organization (CDMO) market covered in this report is segmented –
1) By Product Type: Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy
2) By Phase: Phase 1, Phase 2, Phase 3, Phase 4
3) By Indication: Oncology, Infectious Diseases, Neurological Disorders, Rare Diseases, Other Indications
Subsegments:
1) By Gene Therapy: Viral Vector-Based Gene Therapy, Non-Viral Gene Therapy, Plasmid DNA-Based Gene Therapy
2) By Gene-Modified Cell Therapy: CAR-T Cell Therapy, TCR-T Cell Therapy, NK Cell Therapy
3) By Cell Therapy: Stem Cell Therapy, Progenitor Cell Therapy, Immune Cell Therapy
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=15753&type=smp
What Regions Are Dominating the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Growth?
North America was the largest region in the cell and gene therapy contract development and manufacturing organization (CDMO) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy contract development and manufacturing organization (CDMO) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Reports Similar to the Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market 2025, By The Business Research Company:
Cellular or Mobile Telephone Services Global Market Report 2024
Cell And Gene Therapy Supply Chain/Logistics Global Market Report 2024
Cell and Gene Therapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
